Cover Image

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature

<b>Background:</b> Diabetic retinopathy (DR) is the leading cause of blindness in the working-age population. The purpose of this review is to gather the existing literature regarding the use of the approved anti-vascular endothelial growth (anti-VEGF) agents in the treatment of DR. <...

Full description

Saved in:

Bibliographic Details
Main Authors:	Irini Chatziralli (Author), Anat Loewenstein (Author)
Format:	Book
Published:	MDPI AG, 2021-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short-term effects of intravitreal anti-vascular endothelial growth factor agents on body weight and multiple systems after treatment for retinopathy of prematurity
by: Jing Chen, et al.
Published: (2023)

Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea
by: Hyeon-Jeong Lee, et al.
Published: (2023)

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023)

Current and Future Treatments for Diabetic Retinopathy
by: Francine Behar-Cohen, et al.
Published: (2022)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018)

Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema-A Swiss Cohort Study
by: Ferhat Turgut, et al.
Published: (2024)

Anti-vascular endothelial growth factor treatment in diabetic macular edema
by: Kim M
Published: (2016)

Research of changes in the level of vascular endothelial growth factor in experimental diabetic retinopathy. comparison of methods of correction
by: Ya. Sirman, et al.
Published: (2021)

Characteristics of Eyes Developing Retinal Detachment After Anti-vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity
by: Chiori Kondo, et al.
Published: (2022)

Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
by: Dogra MR, et al.
Published: (2023)

Vascular Endothelial Growth Factor Signaling in Models of Oxygen-Induced Retinopathy: Insights Into Mechanisms of Pathology in Retinopathy of Prematurity
by: Aniket Ramshekar, et al.
Published: (2021)

Investigations of the vascular endothelial factor levels' changes in experimental diabetic retinopathy
by: Nataliya Preys, et al.
Published: (2022)

Relationships of vascular endothelial growth factor (VEGFA) with stage of diabetic retinopathy and disease duration in patients with type 2 diabetes mellitus
by: A. S. Hudz, et al.
Published: (2018)

Anti-Vascular Endothelial Growth Factor Therapy as an Alternative or Adjunct to Pan-Retinal Photocoagulation in Treating Proliferative Diabetic Retinopathy: Meta-Analysis of Randomized Trials
by: Shuang Gao, et al.
Published: (2020)

Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report
by: Ying Huang, et al.
Published: (2022)

Anti-vascular endothelial growth factor agent reduces inflammation in macular edema with central retinal vein occlusion
by: Asako Mashima, et al.
Published: (2019)

Topical nerve growth factor prevents neurodegenerative and vascular stages of diabetic retinopathy
by: Gianpaolo Zerbini, et al.
Published: (2022)

Assessment of the degree of diabetic neuropathy of the optic nerve following intravitreal interventions in proliferative diabetic retinopathy
by: Elhage Emhamed Ali, et al.
Published: (2016)

Intravitreal vascular endothelial growth factor inhibitors did not increase the risk of end-stage renal disease in patients with biopsy-proven diabetic kidney disease based on matched study
by: Xiang Xiao, et al.
Published: (2022)

Occult retinal neovascularization following intravitreal bevacizumab and laser treatment for retinopathy of prematurity
by: Wei Loon Ng, et al.
Published: (2024)

Intraocular pressure effect of intravitreal conbercept injection for retinopathy of prematurity
by: Caifeng Gao, et al.
Published: (2023)

Comparison Of Intravitreal Triamcinolone Injection Vs Laser Photocoagulation in Angiographic Macular Edema in Diabetic Retinopathy
by: Somesh V Aggarwal, et al.
Published: (2012)

Evaluation of intravitreal ranibizumab injection as a line of treatment for chronic central serous retinopathy
by: Emad A.A Saliem
Published: (2019)

Anti-vascular endothelial growth factor receptor in colorectal cancer: A review
by: Alfredo Colombo, et al.
Published: (2023)

Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014)

Different Anti-Vascular Endothelial Growth Factor for Patients With Diabetic Macular Edema: A Network Meta-Analysis
by: Xian Wang, et al.
Published: (2022)

Protective Effect of Fenofibrate on Oxidative Stress-Induced Apoptosis in Retinal-Choroidal Vascular Endothelial Cells: Implication for Diabetic Retinopathy Treatment
by: Ying-Jung Hsu, et al.
Published: (2020)

Evaluation of an Intravitreal Rho-Associated Kinase Inhibitor Depot Formulation in a Rat Model of Diabetic Retinopathy
by: Cecile Lebon, et al.
Published: (2021)

The role of NOS2A -954G/C and vascular endothelial growth factor +936C/T polymorphisms in type 2 diabetes mellitus and diabetic nonproliferative retinopathy risk management
by: Porojan MD, et al.
Published: (2015)

Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
by: Weidemann AK, et al.
Published: (2013)

Vascular Abnormalities and the Role of Vascular Endothelial Growth Factor in the Epileptic Brain
by: Ari Ogaki, et al.
Published: (2020)

Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial
by: Jinfeng Qu, et al.
Published: (2023)

Ultrastructural features of epiretinal membranes after intravitreal injection of various doses of aflibercept in patients with proliferative diabetic retinopathy
by: Vira S. Ponomarchuk, et al.
Published: (2021)

Aggressive Posterior Retinopathy of Prematurity: Long-Term Outcomes Following Intravitreal Bevacizumab
by: Ameay V. Naravane, et al.
Published: (2022)

Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy
by: Francesca Lazzara, et al.
Published: (2024)

Three-dimensional spheroids of choroid-retinal vascular endothelial cells as an in-vitro model for diabetic retinopathy: Proof-of-concept investigation
by: Manish Gore, et al.
Published: (2022)

Vascular endothelial growth factor expression in diabetic nephropathy; a clinico-pathological study
by: Sagarika Sharma, et al.
Published: (2021)

Molecular Biomarkers of Neovascular Age-Related Macular Degeneration With Incomplete Response to Anti-Vascular Endothelial Growth Factor Treatment
by: Irmela Mantel, et al.
Published: (2020)

Nephrotoxicity induced by vascular endothelial growth factor inhibitors
by: Shirinsadat Badri, et al.
Published: (2022)

Morphological and ophthalmoscopic features of epiretinal membranes after intravitreal injection of various doses of aflibercept in patients with proliferative diabetic retinopathy
by: Vira S Ponomarchuk, et al.
Published: (2021)